Monday, June 15, 2026

AMD’s Strong Earnings Overshadowed by 8% Stock Drop in After-Hours Trading

AMD's earnings exceeded expectations, but its stock fell over 8% in after-hours trading, leaving investors wanting more.

K-Beauty and K-Fashion Set to Gain Unexpected Profits from U.S. Tariff Refunds: What You Need to Know

The U.S. is launching a tariff refund system, benefiting K-beauty and K-fashion exporters under DDP terms starting April 20.

‘The Old Woman with the Knife’ Gets Rave Reviews at Berlin Film Fest

"The Old Woman with the Knife," premieres in May after acclaim at Berlinale, featuring a legendary assassin's showdown.

Tag: Neok Bio

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

ABL Bio to Invest Additional $25 Million in Neok Bio to Accelerate ADC Clinical Trials

ABL Bio invests $25M in Neok Bio for bispecific antibody-drug conjugate trials, aiming for FDA-approved treatments by 2027.

Unlocking Cancer Treatment: ABL206 and ABL209’s Promising Non-Clinical Data Revealed at AACR

ABL Bio will present preclinical data for its ADCs ABL206 and ABL209 at AACR 2023, showcasing promising anti-cancer efficacy.

ABL206: First-in-Class Dual Antibody Drug Conjugate Approved for Clinical Trials in the U.S. – What This Means for Cancer Treatment

ABL Bio and Neok Bio received FDA approval for ABL206, a dual-antibody ADC, marking a key milestone in their clinical development efforts.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.